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Abstract A primary focus of the management of type 1 dia-
betes has been on matching prandial insulin therapy with car-
bohydrate amount consumed. However, even with the intro-
duction of more flexible intensive insulin regimes, people
with type 1 diabetes still struggle to achieve optimal
glycaemic control. More recently, dietary fat and protein have
been recognised as having a significant impact on postprandi-
al blood glucose levels. Fat and protein independently in-
crease the postprandial glucose excursions and together their
effect is additive. This article reviews how the fat and protein
in a meal impact the postprandial glycaemic response and
discusses practical approaches to managing this in clinical
practice. These insights have significant implications for pa-
tient education, mealtime insulin dose calculations and dosing
strategies.
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Introduction
Intensive insulin management and good glycaemic control are
essential for the prevention of acute and long-term diabetes
complications and the overall wellbeing in people with type 1
diabetes [1, 2]. Multiple daily injection (MDI) therapy in-
volves injecting long-acting insulin once or twice daily
(basal) and injections of rapid-acting insulin before each meal.
This remains the most common form of insulin therapy for
type 1 diabetes; however, insulin pump therapy (IPT) is be-
coming an increasingly popular form of therapy. An extension
of MDI and IPT is flexible intensive insulin therapy, which
involves calculating the mealtime insulin based on carbohy-
drate (CHO) content of the meal and the pre-prandial blood
glucose level (BGL) [1, 3, 4]. Adjusting insulin doses based
on CHO intake in intensive insulin regimes has been shown to
improve glycaemic control, decrease hypoglycaemia and im-
prove quality of life [1, 3–8]. However, even with the intro-
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duction of intensive insulin regimes, analogue insulins and
CHO quantification, day-to-day glucose variability remains
a major issue [9] and diabetes centres have not seen the antic-
ipated improvements in glycaemic control [10–12]}.
One of the key factors affecting the mean BGL and HbA1c
is the postprandial BGL. Postprandial BGLs have been shown
to increase the risk factors for cardiovascular disease in people
with type 1 diabetes [13, 14]. Hence, factors that increase the
postprandial BGL have the potential to increase HbA1c and
the risk of complications.
Although CHO is the predominant macronutrient affecting
postprandial BGL, recent research has shown that dietary fat
and protein can also significantly impact the postprandial
glycaemic profile (Fig. 1) [16, 17, 18••, 19••], and thus
adjusting the prandial insulin dose for these macronutrients
may be beneficial [16, 20••].
Dietary CHO is digested into glucose (and other monosac-
charides) and transported into the bloodstream, where it di-
rectly raises the blood glucose concentration. Since other mac-
ronutrients, including protein and fat, have little direct impact
on postprandial glycaemia in healthy subjects, they were es-
sentially ignored for determining prandial insulin doses. Early
research in the 1980s confirmed this relationship between
CHO and insulin therapy in type 1 diabetes using an artificial
pancreas [21–23]. Around the same time, there was evidence
to suggest that high-fat and high-protein meals influence ex-
ogenous insulin requirements in type 1 diabetes, however the-
se were largely overlooked in the enthusiasm for carbohydrate
counting ([24, 25].
Optimising insulin dosing for fat and protein is an impor-
tant clinical issue given fat and protein are recommended to
comprise a combined 45–50 % of daily energy intake (∼30 %
for fat and 15–20 % for protein) [26, 27]. Furthermore, low-
CHO diets (with consequently higher intakes of fat and pro-
tein) have recently received a great deal of media attention and
are becoming increasingly popular.
This article will therefore review the evidence regarding the
glycaemic impact of fat and protein and discuss the clinical
implications and mealtime insulin dosing strategies in the
management of type 1 diabetes.
Fat
Glycaemic Impact
Unlike proteins or CHO, fat is rarely consumed in isolation as
a single macronutrient, therefore the impact of fat is usually
considered in terms of its ability to modify the CHO-induced
blood glucose response.
In healthy people and people with type 1 diabetes,
adding fat to a CHO meal reduces the glycaemic re-
sponse in the early postprandial period (first 1–3 h) but
extends the glycaemic response over hours. Using con-
tinuous glucose monitoring (CGM) profiles in 24
healthy non-diabetic adults, Freckmann et al. demon-
strated that meals with a higher fat content induced a
smaller increase and a slower decrease of postprandial
Fig. 1 Continuous glucose sensor results demonstrating the impact of
macronutrients on postprandial glycaemia. Graph A is a 10-year-old
female with type 1 diabetes on insulin pump therapy who was well
controlled but ate pizza at 18:00 (red line). The standard bolus did
cover the first 2 h but then she developed extended hyperglycaemia.
Graph B is an 18-year-old male with type 1 diabetes on insulin pump
therapy who ate fried chicken at 22:00 (blue line). The standard bolus
controlled the initial postprandial period but he developed
hyperglycaemia 3 h later which lasted 6 h. (With permission from:
Smart, C. Diabetes Care for Children and Young People. Diabetes and
Primary Care 2013, 2(2):71–73) [15]
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glucose concentrations than a high-carbohydrate low-fat
meal [28].
As with healthy individuals, the addition of fat tends to
decrease the glycaemic response in the early postprandial pe-
riod in people with type 1 diabetes, and thus increases the risk
of hypoglycaemia. However, in the late postprandial period,
high-fat meals often cause significant hyperglycaemia lasting
for several hours following the meal. This hyperglycaemia is
problematic for good glycaemic control, particularly since
high-fat meals are often consumed for the evening meal when
prolonged hyperglycaemia may not be detected until the fol-
lowing morning. A recent study of the dietary factors associ-
ated with nocturnal hypoglycaemia in adults has shown a
significant association with post-dinner fat intake and higher
rates of nocturnal hyperglycaemia occurrence [29].
Several studies looking at the effects of dietary fat have
been published in recent years. We have shown that the addi-
tion of 35 g of dietary fat to 30 g of CHO initially reduces the
glycaemic excursion for up to 90 min following the meal but
then significantly increases the postprandial glycaemic re-
sponse from 3 h onwards, with the BGL increased by
2.3 mmol/L at 5 h [18••]. In an insulin clamp study, Wolpert
et al. also demonstrated that a high-fat meal (50 g of fat)
causes significant hyperglycaemia over 5 h, even with addi-
tional insulin infused [19••].
Mechanisms of Action
Unlike proteins or CHO, fat is rarely consumed on its own as a
single macronutrient. Triacylglycerols (TAGs) constitute
more than 90 % of lipids in the human diet, and this review
will focus on their role in the management of BGLs.
TAGs can influence the glycaemic response in type 1 dia-
betes by (1) gluconeogenesis of glycerol, (2) a direct effect of
free fatty acids (FFA), (3) effects on other hormones and (4)
effects on gastric emptying.
1. Gluconeogenesis from fat
Dietary fat is not converted to glucose in any substan-
tial amounts. Fatty acids are metabolised to ketones which
cannot be used in gluconeogenesis [30]. In contrast, glyc-
erol from the hydrolysis of TAGs can be metabolised to
pyruvate and synthesised into glucose [30]. However,
glycerol only makes up 5–15 % of the weight of TAGs
(depending on which fatty acids are in the TAG) and only
part of the glycerol would be converted to glucose with
the rest entering the glycolytic pathway [31].
2. Direct effect of fatty acids
Circulating FFAs have a direct effect on the beta cells
causing increased glucose-stimulated insulin secretion,
which has been attributed to interactions with a G
protein-coupled receptor [31]. Additionally, FFAs are
the ligand for peroxisome proliferator-activated receptors
(PPARs). The thiazolidinediones are PPARγ agonists
which are used in the management of type 2 diabetes.
See Grygiel-Gorniak for a review of PPARs [32].
3. Effects of fats on other hormones
Dietary fat has been shown to alter the release of other
hormones which impact on glycaemic regulation includ-
ing glucagon, glucagon-like protein 1 (GLP-1), gastric
inhibitor polypeptide (GIP) and ghrelin.
In healthy subjects, when fat is consumed alone, post-
prandial glucagon and GLP-1 levels increase, but if the fat
is consumed with CHO, the glucagon and GLP-1 levels
do not increase [33]. Ladbroke et al. found that when
adolescents with type 1 diabetes consumed a high-fat
and high-CHO meal, GLP-1, GIP and ghrelin increased
[34]. The impact of dietary fat on other hormones is be-
yond the scope of this article, and the reader is referred to
other reviews [35].
4. Effect of fat on gastric emptying
The duodenal delivery of nutrients is a major determi-
nant of BGL. As the CHO absorption capacity of the
small intestine far exceeds the duodenal delivery, gastric
emptying is a rate-limiting step in glucose absorption [36,
37]. As the stomach empties at a constant energy rate
(8.4 kJ/min), addition of fat to a meal will delay the rate
of gastric emptying of CHO [38]. Addition of fat to a
CHO meal delayed and reduced the glycaemic and
insulinemic responses in healthy individuals [39]. Clegg
et al. showed that in healthy subjects, the chain length and
saturation of fat is important and changes the glycaemic
response to a meal [40].
The impact of dietary fat on gastric emptying of the subse-
quent meal regardless of its content also needs consideration,
as dietary fat from breakfast has been shown to delay the rate
of gastric emptying of the subsequent lunch meal [41]. Fur-
thermore, intake of high-fat diet for 1 week desensitises gas-
trointestinal transit and leads to a more rapid gastric emptying
[42].
Because of fats impact on gastric emptying, modification




In individuals without diabetes, dietary protein does not alter
postprandial glycaemia [43], however, it stimulates a signifi-
cant postprandial insulin response, which is required for ami-
no acid uptake [44]. In order to maintain euglycaemia, protein
concurrently stimulates glucagon secretion, thereby promot-
ing hepatic glucose release and regulation of BGL [45–47].
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In contrast, when people with type 1 diabetes consume
protein, there is an increase in postprandial BGLs and insulin
requirements. Studies comparing the postprandial glycaemic
responses to standardmeals withmeals containing between 28
and 57 g of additional protein have demonstrated significantly
higher postprandial glycaemic excursions and insulin require-
ments in the 2–5 h postprandial period in type 1 diabetes [17,
18••, 45, 48]. More recently, our group looked at the
glycaemic impact of ingested protein only (independent of
CHO and fat) in children and young adults with type 1 diabe-
tes [49]. Consumption of ≥75 g of protein resulted in a signif-
icantly delayed, sustained, elevated, postprandial glycaemic
excursion from 180 to 300 min compared with a control drink
(water). The peak BGL from ≥75 g of protein was similar to
that of 20 g of glucose given without insulin; however, the
shape of the glycaemic response was significantly different.
Following the ingestion of protein, the BGL only began to rise
after 100 min and reached the peak BGL after 5 h.
These findings demonstrate that for people with type 1
diabetes the addition of ≥28 g of protein to a mixed meal or
consuming ≥75 g of protein alone is likely to result in signif-
icant and sustained postprandial hyperglycaemia commencing
in the late postprandial period (2–3 h) and continuing beyond
5 h. Clinically, this is important when determining whether
additional insulin is required and, importantly, how to safely
calculate and distribute these increased doses.
The sustained postprandial hyperglycaemic effect of pro-
tein could potentially be utilised to decrease nocturnal
hypoglycaemia, however, research has shown that high-fat
mea ls (which a l so have sus ta ined pos tprandia l
hyperglycaemia) did not prevent nocturnal hypoglycaemia
[50]. Hence, further research is required to determine if
high-protein meals would decrease nocturnal hypoglycaemia.
Mechanisms of Action
Two mechanisms have been proposed by which dietary pro-
tein may cause delayed and sustained postprandial glycaemic
excursions in people with type 1 diabetes: (1) the alteration of
hormones which affects glucose homeostasis and (2) the con-
version of amino acids to glucose by gluconeogenic pathways.
1. Alteration of hormones which affect glucose homeostasis
Ingestion of a high-protein meal has been shown to
increase circulating plasma glucagon in both healthy peo-
ple and people with type 1 diabetes [45–47]. In people
without diabetes, the concurrent stimulation of glucagon
counters the effects of protein-induced insulin release
(whilst still allowing insulin to transport amino acids into
the cells), and thus, there is minimal impact on postpran-
dial glycaemia. However, in people with type 1 diabetes,
this increase in plasma glucagon in the absence of suffi-
cient insulin has been shown to cause postprandial
hyperglycaemia [45, 51].
Meal protein content also influences a number of other
hormones, such as cortisol, growth hormone, IGF-1 and
ghrelin, but how these hormonal changes subsequently
influence postprandial glucose levels is poorly under-
stood. High-protein meals produce increased cortisol con-
centrations [52], which in turn may increase insulin resis-
tance and insulin requirements. Meals that are high pro-
tein and low CHO produce increased growth hormone
levels; however, when the meal contains significant
amounts of CHO, growth hormone is unchanged or de-
creased [53]. Meals high in protein increase circulating
IGF-1 levels and decrease ghrelin levels [54].
2. Conversion of amino acids to glucose (gluconeogenesis)
Amino acids can act as an energy source by being
converted to glucose (glucogenic amino acids) or into
ketone bodies (ketogenic amino acids). There are 20 ami-
no acids that are encoded by the nuclear genes of eukary-
otes, 13 are exclusively glucogenic, 2 are exclusively ke-
togenic and 5 are glucogenic and ketogenic. Hence, 18 out
of the 20 amino acids (90 %) can be converted to glucose.
The exclusively glucogenic amino acids are glycine, ser-
ine, valine, histidine, arginine, cysteine, proline, alanine,
glutamate, glutamine, aspartate, asparagine and methio-
nine. The amino acids that are both glucogenic and keto-
genic are isoleucine, threonine, phenylalanine, tyrosine
and tryptophan. The exclusively ketogenic amino acids
are leucine and lysine [55]. When circulating insulin
levels are inadequate, there is an uptake of glucogenic
amino acids by the liver, thereby increasing gluconeogen-
esis and resulting in increased plasma BGL [56–58].
A study by Khan et al. showed that 50 g of ingested protein
resulted in an additional 9.7+/−5.7 g of glucose in the circu-
lation over 8 h in healthy adult males [43]. This demonstrates
that by weight, 19.4 % of the total amount of protein ingested
can be converted to glucose. However, considering only the
amount of glucose that enters the circulation ignores the
protein-induced hormonal response (as discussed above) and
that some additional insulin may be needed to counter the
resulting decrease in insulin sensitivity.
Alternatively, Pańkowska et al. have proposed that 100 kcal
of fat/protein requires the equivalent amount of insulin as 10 g
of glucose [16, 59]. Using this ratio (protein contains 4.1 kcal/
g), 100 kcal of protein=24.4 g of protein=10 g of glucose.
This is approximately twice the amount of glucose that Khan
and colleagues found was produced from protein in healthy
volunteers [43]. This apparent discrepancy may be explained
because Khan et al. measured the amount of glucose pro-
duced, whereas Pańkowska et al. used clinical response
(which would account for glucose production and hormonal
responses). Kordonouri et al. used the Pańkowska equation in
children with type 1 diabetes using IPT and found that
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although glycaemic control was improved, the risk of post-
prandial hypoglycaemia was increased threefold [20••]. This
suggests that further research is required to determine how
much additional insulin is required to cover the protein com-
ponent of a meal.
Combining Fat and Protein
Although both protein and fat can independently in-
crease postprandial glycaemia in type 1 diabetes, most
meals contain both fat and protein so it is important to
consider the impact of these nutrients in combination.
Our research has revealed that when both fat and pro-
tein are added to a meal, their glycaemic impacts are
additive. The addition of 30 g of fat to 30 g of CHO
increased glycaemia by 1.8 mmol/L at 5 h, and similar-
ly, the addition of 40 g of protein to the same amount
of CHO increased glycaemia by 2.4 mmol/L at 5 h
[18••]. However when both nutrients were added to
the meal, the postprandial glycaemic response was in-
creased by 5.4 mmol/L, the sum of the effects of the
two nutrients individually [18••].
Our results are supported by other studies in the literature.
Neu et al. showed that the addition of 82 g of protein and 33 g
of fat to 70 g of protein increased the glucose response by
40% over 12 h, with significant differences in glycaemia seen
from 4 to 12 h and the peak difference observed 6 h following
the meal [60]. Similarly, Garcia-Lopez et al. found that the
glucose profile varied significantly with time when both fat
and protein were added to a CHOmeal.When the low protein/
fat meal was consumed, the peak BGL was reached after 1 h
and returned to baseline by 3 h. However, when fat and protein
were added to the same meal, the peak BGL was delayed by
30 min but stayed elevated for the remainder of the 3 h test
session and did not return to baseline [48].
Dosing Insulin for Fat and Protein
As both fat and protein increase postprandial glycaemia be-
yond that of CHO alone, effective strategies to adjust insulin
doses for these macronutrients are required. It is important to
note that in practice, people consume mixed meals containing
combinations of CHO, protein and fat, and therefore, the over-
all impact of these macronutrients on postprandial BGLs
needs to be considered rather than the effect on individual
nutrients. When determining how to administer insulin for
meals with varying CHO, fat and/or protein contents, it is
important to consider the effects in terms of managing both
the early and late postprandial glycaemic responses.
Controlling the Immediate Postprandial Glycaemic
Response
Managing the early postprandial period is the first step in
adjusting mealtime insulin doses, as changes implemented
here will have flow-on effects for the late postprandial period.
For high CHO meals, controlling the immediate postpran-
dial glycaemic rise is important as an increased initial glucose
spike can increase the entire postprandial excursion [61]. For
example, an increase in the early postprandial response by
2 mmol/L, with a consequential increase in BG at all time
points, could result in a 2–3× fold greater glycaemic excur-
sion. This is especially true for meals also containing signifi-
cant amounts of fat and protein, which will further increase the
late postprandial period.
Changing the timing of the insulin bolus to minimise the
immediate postprandial response has been investigated, how-
ever, not in the context of high-fat and/or high-protein meals.
Although the immediate postprandial glucose rise is blunted
after a high-fat meal, there is still a need for insulin to cover
the CHO component of the meal [18••]. Therefore, in the
author’s opinion, delaying the insulin injection for high-fat
mea l s wou ld cau se unaccep t ab l e po s tp r and i a l
hyperglycaemia. Research looking at the timing of the insulin
bolus has shown that giving the insulin bolus before starting to
eat gives superior glycaemic control compared to delaying the
insulin bolus [61–63]. Conversely, for high-CHO meals also
containing fat and protein, two studies have shown that dosing
insulin 15 min prior to the meal was able to improve control
over the initial postprandial spike, significantly reducing the
peak BGL [62, 64]. However, in practice, dosing 15 min prior
to a meal may prove too onerous for some patients and may
result in insulin doses being forgotten. As with all diabetes
management recommendations, advice should be tailored to
the individual.
For patients using IPT, the insulin delivery pattern can be
adjusted to better match insulin requirements. The bolus for a
meal can be given as a standard bolus (where the entire dose is
given within 5 min), an extended bolus (where the dose is
infused at a constant rate over a chosen number of hours) or
a combination bolus (where a proportion of the dose is deliv-
ered immediately and the remainder is infused continuously as
an extended bolus). However, not all boluses are able to con-
trol the immediate postprandial rise [65, 66]. Chase et al.
found that extended boluses did not control the immediate
postprandial glucose rise with a high-fat meal [65]. Lopez
et al. attempted to optimise the amplitude (height of the wave)
of the extended bolus but was not able to control the immedi-
ate postprandial glucose rise compared to the standard bolus
[66].
Hypoglycaemia in the early postprandial period is also a
concern for low-CHO meals containing significant amounts
of protein and/or fat, with patients often reporting
Curr Diab Rep (2015) 15: 61 Page 5 of 9 61
hypoglycaemia soon after the meal when insulin is dosed up-
front. This is likely due to mismatch between the rapid-acting
insulin and the delayed gastric emptying following fat and the
delayed glycaemic responses for both protein and fat. For
these meals, the initial insulin dose needs to be reduced up-
front but potentially increased in the latter phase, with the total
dose delivered over an extended period to match the food
absorption.
Changing the type of insulin delivered is an option for
reducing the risk of early hypoglycaemia with MDI. To our
knowledge, there are no studies comparing regular insulin
with rapid-acting insulin (such as aspart or lispro insulin) for
high-fat and/or high-protein meals. However, in theory, regu-
lar insulin with its slower onset of action and longer duration
of action may offer an advantage in meals high in fat where
gastric emptying is delayed and the initial postprandial glu-
cose rise is blunted [18••].
Controlling the Late Postprandial Glycaemic Response
Fat and protein cause increased glycaemia continuing to 6–
12 h after meal ingestion [16, 18••, 20••, 50]. To cover this
extended glycaemic effect of fat and/or protein, the duration of
the insulin effect needs to be extended and total dosemay need
to be increased.
There is much debate over how additional insulin doses
should be calculated and how much protein or fat needs to
be consumed before insulin doses need to be adjusted. Two
different algorithms have been proposed to calculate insulin
for meal fat and protein content. Pankowska et al. have pro-
posed that the insulin dose for 10 g of CHO should be equiv-
alent to the insulin needed for every 100 kcal of fat/protein.
Alternatively, Brand-Miller et al. have proposed a food insulin
index, which is a measure of the postprandial insulin response
to foods in healthy subjects, as a basis for determining meal-
time insulin doses in type 1 diabetes [12, 67, 68]. However,
both of these methods have resulted in significant postprandial
hypoglycaemia and require further research.
Closed-loop studies have suggested that for high-fat and/or
high-protein meals, the insulin dose needs to be increased by
42 % to as much as 125 %. Wolpert et al. revealed a mean
insulin dose increase of 42 % was needed for a high-fat meal
(60 g fat) compared to the low-fat meal (10 g fat), however,
given patients still experienced significantly hyperglycaemia
following the high-fat meal, this dose is likely to be an under-
estimation [19••]. Importantly, there was a wide variation in
the dose adjustment needed to cover the high-fat meal (range
−17 to +108%), highlighting the importance of individualised
advice. A subsequent study by this group used predictive
modelling to optimise the insulin dose in patients using insulin
pump therapy for the addition of 35 g of fat and 32 g of protein
to a meal, finding a mean insulin dose increase of 78 %, using
a combination-wave with 30/70 % split over 2.4 h [69].
Similarly, there was a wide variation in the total dose increase
(+38 to +125 %) and the optimal split and duration (range 20/
80 % to 50/50 % and 2–3 h).
Since rapid-acting insulin given as a standard bolus will not
last long enough to cover the long tail caused by protein and
fat, altering the insulin delivery pattern (i.e., bolus type) may
assist with controlling late postprandial hyperglycaemia in
patients using IPT. Extended boluses are also ineffective for
high-protein/fat meals, as they are unable to control the im-
mediate postprandial BGL rise [65, 66, 70], even though the
rate of the rise is blunted [18••]. Currently, the most effective
form of insulin pump bolus for meals containing protein and/
or fat is the combination-wave bolus [65, 70, 71]. Jones et al.
demonstrated that compared with a standard bolus, a
combination-wave bolus significantly reduced the mean
BGL and improved the amount of time spent within the nor-
mal BGL range for a high-fat pizza meal [71]. Similarly,
Chase et al. also found that the combination-wave gave the
best postprandial glycaemic control following a high-fat pizza
and tiramisu meal [65]. To date, there are no studies looking at
the optimal split of insulin between the immediate and extend-
ed bolus components for combination-wave boluses. Howev-
er, studies have used 50 % of insulin given immediately and
50 % given as the extended bolus, and this can be used as an
appropriate starting point in practice and adjusted as needed.
The duration has been found to have an improved glycaemic
profile when the duration of the bolus is increased from be-
tween 4 and 8 h [5].
Extending the insulin action time is more problematic for
patients using MDI. Theoretically, the insulin injection could
be given as a split bolus with two separate injections: one
injection prior to the meal and the other given 1 h following
the meal. However, this method needs to be investigated to
determine its efficacy in practice.
For small meals and snacks, large adjustments of insulin
doses may not be required. Wilson et al. compared a low-fat
(30 g CHO, 2.5 g protein, 1.3 g fat; 138 kcal) and a high-fat
(30 g CHO, 2 g protein, 20 g fat; 320 kcal) snack at bedtime
and showed that during an 8-h overnight period, the average
BGL following the low-fat snack was 8.7 and 9.5 mmol/L
following the high-fat snack [50]. In this scenario with a
high-fat snack (rather than a large meal), a standard bolus
for the CHO component and a temporary 10 % increase in
basal overnight would appear appropriate.
Conclusion
Although CHO is the principal factor influencing glycaemic
response to a meal, dietary fat and protein have a major impact
on postprandial glycaemia in people with type 1 diabetes,
from 2 to 8 h after ingestion. Insulin strategies to control the
glycaemic impact of high-fat and high-protein meals require
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further investigation, but the literature suggests increasing the
insulin dose and delivering the insulin using a combination-
wave over at least 2 h improves the post prandial glycaemic
control. Further research is required to produce a pragmatic
approach to dietary fat and protein that can be utilised in
clinical practice.
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